OTCMKTS:SHTDF Sinopharm Group (SHTDF) Stock Price, News & Analysis → AI finds its first serious application (From Wall Street Star) (Ad) Free SHTDF Stock Alerts $2.89 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$2.89▼$2.8950-Day Range$2.46▼$2.9552-Week Range$2.30▼$3.63VolumeN/AAverage Volume752 shsMarket CapitalizationN/AP/E Ratio2.90Dividend Yield9.00%Price TargetN/A Stock AnalysisStock AnalysisChartFinancialsShort InterestStock AnalysisChartFinancialsShort Interest Get Sinopharm Group alerts: Email Address Sinopharm Group MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestBearishDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.53Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.58 out of 5 stars N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Sinopharm Group. Previous Next 2.0 Short Interest Percentage of Shares ShortedShort Interest Ratio / Days to CoverSinopharm Group has a short interest ratio ("days to cover") of 3621, which indicates bearish sentiment.Change versus previous monthShort interest in Sinopharm Group has recently decreased by 37.30%, indicating that investor sentiment is improving significantly. Previous Next 1.7 Dividend Strength Dividend YieldSinopharm Group pays a meaningful dividend of 1.11%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthSinopharm Group does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Sinopharm Group is 26.05%. This payout ratio is at a healthy, sustainable level, below 75%. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for SHTDF. Previous Next 2.5 News and Social Media Coverage News SentimentSinopharm Group has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.34 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Sinopharm Group this week, compared to 0 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Sinopharm Group insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 16.47% of the stock of Sinopharm Group is held by institutions. Previous Next 1.3 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Sinopharm Group is 2.90, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 130.14.Price to Earnings Ratio vs. SectorThe P/E ratio of Sinopharm Group is 2.90, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 155.90. Previous Next See Top Rated MarketRank™ Stocks Here Ad Wall Street StarAI finds its first serious applicationAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Sinopharm Group Stock (OTCMKTS:SHTDF)Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.Read More SHTDF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SHTDF Stock News HeadlinesApril 29, 2024 | marketwatch.comSinopharm Group Shares Fall as Higher Costs Cut Into Quarterly ProfitApril 20, 2024 | americanbankingnews.comSinopharm Group (OTCMKTS:SHTDF) Shares Pass Below Two Hundred Day Moving Average of $2.61April 29, 2024 | The Bull Report (Ad)Healthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.April 6, 2024 | morningstar.comSinopharm Group Co Ltd ADR X2S1February 21, 2024 | morningstar.comSinopharm Group Co Ltd 01099January 30, 2024 | morningstar.comSinopharm Group Co Ltd X2SNovember 8, 2023 | morningstar.comSinopharm Group Co Ltd SHTDFMay 12, 2023 | msn.comSinopharm Group (HKEX:1099) Price Target Increased by 8.31% to 29.48April 29, 2024 | The Bull Report (Ad)Healthcare Takes A Big Step Forward With The Help Of AIThe average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.April 13, 2023 | finance.yahoo.comPfizer signs strategic cooperation pact with China's SinopharmApril 6, 2023 | msn.comWHO chief expects COVID emergency to end this yearMarch 24, 2023 | msn.comChina approves its first mRNA Covid-19 vaccineMarch 22, 2023 | news.yahoo.comChina approves first home-grown mRNA Covid vaccineFebruary 23, 2023 | forbes.comSinopharm GroupJanuary 20, 2023 | news.yahoo.comSinopharm unit gets OK for clinical trials of mRNA COVID vaccineJanuary 20, 2023 | msn.comPharma major Sinopharm gets approval for clinical trials of mRNA Covid-19 vaccineDecember 8, 2022 | reuters.comSinopharm's second Chinese herb shot is potentDecember 2, 2022 | seekingalpha.comVaxxinity says COVID vaccine outperformed Astra and Sinopharm shots as boosterSeptember 28, 2022 | seekingalpha.comMerck in pact with Sinopharm to launch oral COVID-19 therapy in ChinaSeptember 15, 2022 | msn.comSinopharm to boost local COVID vaccine production in AfricaSeptember 7, 2022 | msn.comChina’s Sinovac to test Omicron-targeting vaccines in ChileJuly 27, 2022 | msn.comDaesang to set up joint venture with China Sinopharm InternationalJuly 17, 2022 | seekingalpha.comWeek In Review: Qiming Closes $3.2 Billion For China Healthcare And Technology InvestmentsJuly 4, 2022 | msn.comHong Kong could have 3 Omicron-targeting jabs by end of year, as health expert reveals Sinopharm hopes to make new vaccine available by DecemberJune 27, 2022 | msn.comChina Donates 10 Mil Doses of Sinopharm COVID-19 Vaccines, SyringesJune 22, 2022 | usnews.comSome Omicron Sub-Variants Escaping Antibodies From Sinopharm Shot -Chinese StudyJune 21, 2022 | reuters.comSome Omicron sub-variants escaping antibodies from Sinopharm shot - Chinese studySee More Headlines Receive SHTDF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolOTCMKTS:SHTDF CUSIPN/A CIK1556605 Webir.sinopharmgroup.com.cn Phone86-21-2305-2666FaxN/AEmployees115,959Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio2.90 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesMr. Qingming Yu (Age 60)Executive Chairman of the Board Comp: $896.33kMr. Yong Liu (Age 55)President & Executive Director Comp: $866.78kMs. Xiaojuan Li (Age 48)Chief Financial Officer Mr. Yijian Wu (Age 54)Secretary to the Board, Company Secretary & Authorised Representative Key CompetitorsAlfresaOTC:ARHCFArjo AB (publ)OTCMKTS:ARRJFEBOS GroupOTCMKTS:EBOSFGalenicaOTCMKTS:GALNFMcKesson EuropeOTCMKTS:CAKFYView All Competitors SHTDF Stock Analysis - Frequently Asked Questions How have SHTDF shares performed in 2024? Sinopharm Group's stock was trading at $2.49 at the beginning of the year. Since then, SHTDF shares have increased by 16.1% and is now trading at $2.89. View the best growth stocks for 2024 here. Are investors shorting Sinopharm Group? Sinopharm Group saw a decline in short interest in April. As of April 15th, there was short interest totaling 1,448,400 shares, a decline of 37.3% from the March 31st total of 2,310,200 shares. Based on an average trading volume of 400 shares, the short-interest ratio is currently 3,621.0 days. View Sinopharm Group's Short Interest. Is Sinopharm Group a good dividend stock? Sinopharm Group (OTCMKTS:SHTDF) pays an annual dividend of $0.26 per share and currently has a dividend yield of 1.11%. The dividend payout ratio is 26.05%. This payout ratio is at a healthy, sustainable level, below 75%. How do I buy shares of Sinopharm Group? Shares of SHTDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:SHTDF) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportHe Is Giving Away BitcoinCrypto Swap ProfitsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sinopharm Group Co. Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.